American firms Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire&...
US headquartered STARLIMS, a leading provider of enterprise informatics solutions, has announced the expansion of i...
German firm Sartorius and US-based Repligen Corporation have announced the launch of an integrated bioreactor ...
US-based Thermo Fisher Scientific has announced a new line of Thermo Scientific TSG Series Refrigerators to ensure ...
US-based Waters Corporation has introduced the first in a new line of size exclusion chromatography (SEC) columns aimed ...
US-based Waters Corporation has launched its new PeptideWorks Tryptic Protein Digestion Kits to provide biopharma scient...
China headquartered life sciences company Fapon has announced the launch of its latest chemiluminescence immunoassa...
US-based Quest Diagnostics has announced the launch of a novel prostate cancer biomarker test through its subspecialty p...
To address challenges with error-prone, manual molecular testing workflows, US-based Thermo Fisher Scientific has introd...
Japan-headquartered Eisai Co. and US-based Biogen Inc. have announced that the US Food and Drug Administration...
Hitachi, Ltd. has entered a strategic framework collaboration agreement with the world-renowned medical research institu...
Waters Corporation has announced a multi-year research collaboration with Princeton University, in the US, that will ena...
Indian biotech firm Leucine Rich Bio, South Asia’s first microbiome company, is all set to foray into US healthcar...
US-based Illumina Inc., a global leader in DNA sequencing and array-based technologies, has announced that its Board of ...
Fujifilm Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells (iPS...
The US Food and Drug Administration (FDA) has approved the oral anti-viral Paxlovid (nirmatrelvir tablets and ritonavir ...
Sciex, a global leader in life science analytical technologies, recently celebrated the opening of the Echo MS Centre of...
New York-based healthtech company creation platform Ascertain is investing $12 (A$18) million in Eyetelligence, a ...